# Northwest Biotherapeutics Inc: Form 10-K/A for the period ended Dec 31, 2021

- Company: [Northwest Biotherapeutics Inc](/companies/nwbo.md) (CIK 1072379)
- Form: 10-K/A
- Filed: 2022-05-02
- Accepted by EDGAR: May 2, 2022, 17:03 ET
- Period: 2021-12-31
- Accession: 0001104659-22-054757
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1072379/000110465922054757/tm2214170d1_10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1072379/000110465922054757/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1072379/000110465922054757/tm2214170d1_10ka.htm

Filed May 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-054757. Last ingested by Listed: Oct 30, 2026, 16:18 ET. No prices; not investment advice.